N-Acetyl-L-Citrulline

Identification

Generic Name
N-Acetyl-L-Citrulline
DrugBank Accession Number
DB02368
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 217.2224
Monoisotopic: 217.106255983
Chemical Formula
C8H15N3O4
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UN-acetylornithine carbamoyltransferaseNot AvailableXanthomonas campestris pv. campestris (strain ATCC 33913 / NCPPB 528 / LMG 568)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as n-acyl-l-alpha-amino acids. These are n-acylated alpha amino acids which have the L-configuration of the alpha-carbon atom.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
N-acyl-L-alpha-amino acids
Alternative Parents
Fatty acids and conjugates / Acetamides / Ureas / Secondary carboxylic acid amides / Monocarboxylic acids and derivatives / Carboxylic acids / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives
show 1 more
Substituents
Acetamide / Aliphatic acyclic compound / Carbonic acid derivative / Carbonyl group / Carboxamide group / Carboxylic acid / Fatty acid / Hydrocarbon derivative / Monocarboxylic acid or derivatives / N-acyl-l-alpha-amino acid
show 8 more
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
N-acetyl-L-amino acid, N-acetylcitrulline (CHEBI:49002)
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
WMQMIOYQXNRROC-LURJTMIESA-N
InChI
InChI=1S/C8H15N3O4/c1-5(12)11-6(7(13)14)3-2-4-10-8(9)15/h6H,2-4H2,1H3,(H,11,12)(H,13,14)(H3,9,10,15)/t6-/m0/s1
IUPAC Name
(2S)-5-(carbamoylamino)-2-acetamidopentanoic acid
SMILES
CC(=O)N[C@@H](CCCNC(N)=O)C(O)=O

References

General References
Not Available
KEGG Compound
C15532
PubChem Compound
656979
PubChem Substance
46506512
ChemSpider
571213
ChEBI
49002
ZINC
ZINC000012494450
PDBe Ligand
OLN
PDB Entries
3kzk

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility3.57 mg/mLALOGPS
logP-2ALOGPS
logP-1.9Chemaxon
logS-1.8ALOGPS
pKa (Strongest Acidic)3.87Chemaxon
pKa (Strongest Basic)-1.5Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count4Chemaxon
Polar Surface Area121.52 Å2Chemaxon
Rotatable Bond Count6Chemaxon
Refractivity50.77 m3·mol-1Chemaxon
Polarizability21.49 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption-0.5313
Blood Brain Barrier+0.9165
Caco-2 permeable-0.8278
P-glycoprotein substrateNon-substrate0.5218
P-glycoprotein inhibitor INon-inhibitor0.968
P-glycoprotein inhibitor IINon-inhibitor0.9719
Renal organic cation transporterNon-inhibitor0.9455
CYP450 2C9 substrateNon-substrate0.7055
CYP450 2D6 substrateNon-substrate0.7978
CYP450 3A4 substrateNon-substrate0.7317
CYP450 1A2 substrateNon-inhibitor0.9367
CYP450 2C9 inhibitorNon-inhibitor0.8971
CYP450 2D6 inhibitorNon-inhibitor0.9649
CYP450 2C19 inhibitorNon-inhibitor0.8969
CYP450 3A4 inhibitorNon-inhibitor0.7553
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.986
Ames testNon AMES toxic0.7118
CarcinogenicityNon-carcinogens0.9188
BiodegradationReady biodegradable0.9769
Rat acute toxicity1.6137 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9824
hERG inhibition (predictor II)Non-inhibitor0.9697
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0006-9400000000-7401e8328e755c9a54fe
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0n29-0950000000-02adbbfc69d67fc92e79
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00fr-0900000000-22761ac0a91d7aa01f7e
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-03di-1900000000-a5dc3773a18e83eb4864
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-2900000000-d0e76f5833aab08d830a
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-03di-9600000000-582edaf4e8a7ff677dfd
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9200000000-a2636b31548d54af257a
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-154.9696185
predicted
DarkChem Lite v0.1.0
[M-H]-154.7972185
predicted
DarkChem Lite v0.1.0
[M-H]-139.63414
predicted
DeepCCS 1.0 (2019)
[M+H]+155.0424185
predicted
DarkChem Lite v0.1.0
[M+H]+155.0460185
predicted
DarkChem Lite v0.1.0
[M+H]+141.99214
predicted
DeepCCS 1.0 (2019)
[M+Na]+155.1269185
predicted
DarkChem Lite v0.1.0
[M+Na]+155.0500185
predicted
DarkChem Lite v0.1.0
[M+Na]+149.88234
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Xanthomonas campestris pv. campestris (strain ATCC 33913 / NCPPB 528 / LMG 568)
Pharmacological action
Unknown
General Function
N-acetylornithine carbamoyltransferase activity
Specific Function
Catalyzes the conversion of N-acetylornithine to N-acetylcitrulline in an alternative arginine biosynthesis pathway. The enzyme has no activity with ornithine.
Gene Name
argF'
Uniprot ID
Q8P8J2
Uniprot Name
N-acetylornithine carbamoyltransferase
Molecular Weight
37872.96 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at July 02, 2020 13:15